Oxazolo[5,4-f]quinoxaline-type selective inhibitors of glycogen synthase kinase-3α (GSK-3α): Development and impact on temozolomide treatment of glioblastoma cells
Titel:
Oxazolo[5,4-f]quinoxaline-type selective inhibitors of glycogen synthase kinase-3α (GSK-3α): Development and impact on temozolomide treatment of glioblastoma cells
Auteur:
Hasyeoui, Mohamed Lassagne, Frédéric Erb, William Nael, Manal Elokely, Khaled M. Chaikuad, Apirat Knapp, Stefan Jorda, Adrian Vallés, Soraya L. Quissac, Emie Verreault, Maïté Robert, Thomas Bach, Stéphane Samarat, Ali Mongin, Florence